Patient-Reported Efficacy of Subcutaneous Abatacept in Rheumatoid Arthritis: An Evaluation Of Patients In a Compassionate Use Programme in South Africa
Phase of Trial: Clinical Phase Unknown
Latest Information Update: 13 Feb 2016
At a glance
- Drugs Abatacept (Primary)
- Indications Rheumatoid arthritis
- Focus Expanded access; Therapeutic Use
- Sponsors Bristol-Myers Squibb
- 13 Feb 2016 Last checked against ClinicalTrial.gov record.
- 05 Feb 2016 Status changed from active, no longer recruiting to completed, according to ClinicalTrials.gov record.